Bicocca Open Archive

Logo unimib boa
CHINELLO, CLIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.810
AS - Asia 9.037
EU - Europa 7.994
SA - Sud America 1.261
AF - Africa 200
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 12
Totale 34.345
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.018
SG - Singapore 3.095
IT - Italia 2.206
CN - Cina 1.973
VN - Vietnam 1.430
DE - Germania 1.140
HK - Hong Kong 1.073
RU - Federazione Russa 956
BR - Brasile 940
SE - Svezia 753
IE - Irlanda 734
CA - Canada 665
GB - Regno Unito 463
FR - Francia 354
IN - India 298
AT - Austria 286
UA - Ucraina 262
BD - Bangladesh 193
FI - Finlandia 171
KR - Corea 147
ES - Italia 131
ID - Indonesia 125
NL - Olanda 117
AR - Argentina 108
PL - Polonia 103
IQ - Iraq 94
TR - Turchia 92
DK - Danimarca 89
JP - Giappone 85
MX - Messico 70
ZA - Sudafrica 70
PK - Pakistan 54
SA - Arabia Saudita 52
EC - Ecuador 51
BE - Belgio 48
PH - Filippine 48
UZ - Uzbekistan 42
CH - Svizzera 41
MA - Marocco 39
VE - Venezuela 37
CO - Colombia 35
AU - Australia 28
IR - Iran 27
CL - Cile 26
CZ - Repubblica Ceca 22
LT - Lituania 22
MY - Malesia 21
EG - Egitto 19
PE - Perù 19
RO - Romania 19
IL - Israele 18
PY - Paraguay 18
AZ - Azerbaigian 17
UY - Uruguay 16
AE - Emirati Arabi Uniti 15
JO - Giordania 15
ET - Etiopia 14
KZ - Kazakistan 14
TW - Taiwan 14
DZ - Algeria 12
KE - Kenya 12
TH - Thailandia 12
DO - Repubblica Dominicana 11
BO - Bolivia 10
EU - Europa 10
PS - Palestinian Territory 10
BG - Bulgaria 9
HN - Honduras 9
KG - Kirghizistan 9
NP - Nepal 9
PT - Portogallo 9
GR - Grecia 8
LB - Libano 8
LV - Lettonia 8
PA - Panama 8
OM - Oman 7
TN - Tunisia 7
AL - Albania 6
NO - Norvegia 6
SY - Repubblica araba siriana 6
BH - Bahrain 5
CR - Costa Rica 5
HR - Croazia 5
JM - Giamaica 5
MN - Mongolia 5
QA - Qatar 5
SV - El Salvador 5
BB - Barbados 4
BY - Bielorussia 4
KH - Cambogia 4
MT - Malta 4
NG - Nigeria 4
RS - Serbia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
Totale 34.300
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.129
Singapore 1.815
Ashburn 1.615
San Jose 1.162
Hong Kong 1.040
Milan 839
Fairfield 775
Dublin 724
Chandler 722
Frankfurt am Main 666
Woodbridge 626
Houston 546
Wilmington 532
Ho Chi Minh City 442
Toronto 421
New York 419
Dallas 403
Los Angeles 364
Dearborn 358
Santa Clara 338
Hanoi 336
Seattle 330
Beijing 276
Vienna 251
Cambridge 244
Jacksonville 234
Chicago 219
Hefei 191
Shanghai 185
The Dalles 183
Princeton 175
São Paulo 140
Nanjing 136
Seoul 129
Buffalo 121
Council Bluffs 119
Lauterbourg 111
Orem 101
Boardman 95
Moscow 93
Munich 86
Helsinki 79
Jakarta 73
Columbus 69
Montreal 65
Da Nang 64
London 64
Lawrence 63
Warsaw 63
Altamura 62
Guangzhou 61
Fremont 59
Kent 59
Nanchang 58
Denver 56
Tokyo 54
Brooklyn 53
North Kansas City 50
Dong Ket 48
Atlanta 47
Nuremberg 47
Chennai 46
Baghdad 43
Haiphong 43
Amsterdam 42
Brussels 42
Rome 42
Ottawa 41
Stockholm 41
Lachine 40
San Diego 40
Johannesburg 39
Montréal 38
San Francisco 38
Tashkent 38
Rio de Janeiro 34
Hải Dương 33
Phoenix 33
Shenyang 32
Turku 31
Boston 30
Manchester 30
Biên Hòa 29
Changsha 29
Zhengzhou 29
Paris 28
Washington 28
Florence 27
Lissone 27
Ninh Bình 27
Salt Lake City 27
Poplar 26
Tianjin 26
Zurich 26
Andover 25
Pune 24
Hebei 23
Mumbai 23
Dhaka 22
Düsseldorf 22
Totale 22.149
Salva come PNG Salva come JPEG
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 584
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 576
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 565
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 552
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 540
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 512
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 483
Differential protein profiling of renal cell carcinoma urinary exosomes 469
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 456
Urinary exosomes and diabetic nephropathy: a proteomic approach 455
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 450
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 439
The putative role of MALDI-MSI in the study of Membranous Nephropathy 429
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 421
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 420
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 416
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 411
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 400
The proteomic landscape of renal tumors 400
Mutual Information Optimization for Mass Spectra Data Alignment 379
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 376
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 373
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 371
Proteomics imaging and the kidney 370
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 370
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 363
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 363
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 362
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 362
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 355
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 351
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 351
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 350
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 349
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 347
Robust conclusions in mass spectrometry analysis 346
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 339
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 336
Poster: Characterization of distinguishing regions for renal cell carcinoma discrimination 335
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 335
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 333
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 332
Tumor size, stage and grade alterations of urinary peptidome in RCC 320
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 320
Proteome analysis in thyroid pathology 317
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 312
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 312
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 310
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 307
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 304
Analysis of correlation structures in renal cell carcinoma patient data 303
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 294
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 294
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 289
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 287
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 287
A molecular imaging approach to individuate tumour infiltrating lymphocytes 287
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 286
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 282
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 281
Intraluminal proteome and peptidome of human urinary extracellular vesicles 280
AQP1 expression analysis in human diseases: Implications for proteomic characterization 279
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 278
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 278
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 277
Imaging mass spectrometry: a new tool for kidney disease investigations 275
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 271
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 270
Detection of high molecular weight proteins by MALDI imaging mass spectrometry 268
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 262
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 260
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 257
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 252
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 245
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 243
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 243
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 241
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 237
Proteomic investigation of therapy induced senescence in cancer cells by a DIA-PASEF mass spectrometry approach 236
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 234
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 233
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 232
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 227
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 225
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 225
Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry 211
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 209
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 209
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 206
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 199
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 199
Immunoreattività e carcinoma renale 195
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 192
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 189
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 187
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 186
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 184
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 183
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 180
Method for the in vitro diagnosis of thyroid diseases 176
Totale 31.751
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021234 0 0 0 0 0 0 0 0 0 0 0 234
2021/20221.539 145 146 134 196 79 127 54 96 60 123 149 230
2022/20232.911 299 818 282 322 148 416 38 183 191 35 94 85
2023/20242.325 68 67 106 173 249 652 481 56 144 44 53 232
2024/20255.434 222 473 345 220 481 215 318 222 558 943 587 850
2025/202614.449 1.940 753 1.169 1.689 1.665 717 2.152 552 1.055 1.252 994 511
Totale 35.239